CMS Belgium advised Graftys and its shareholders on the deal.Graftys and its shareholders, a Belgian Medtech company specializing in the development and manufacturing of synthetic bone…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Giulia Di Palma
…
This content is for Standard 1 Year members only. LoginJoin Now